3.48
price down icon6.20%   -0.23
 
loading
전일 마감가:
$3.71
열려 있는:
$3.7
하루 거래량:
43,817
Relative Volume:
0.48
시가총액:
$10.37M
수익:
-
순이익/손실:
$-22.01M
주가수익비율:
-0.5273
EPS:
-6.6
순현금흐름:
$-18.31M
1주 성능:
-4.53%
1개월 성능:
+29.37%
6개월 성능:
-35.56%
1년 성능:
-71.75%
1일 변동 폭
Value
$3.37
$3.9499
1주일 범위
Value
$3.04
$3.9499
52주 변동 폭
Value
$1.39
$13.02

Vaccinex Inc Stock (VCNX) Company Profile

Name
명칭
Vaccinex Inc
Name
전화
585-271-2700
Name
주소
1895 MOUNT HOPE AVE, ROCHESTER, NY
Name
직원
40
Name
트위터
@Vaccinex
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
VCNX's Discussions on Twitter

VCNX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
VCNX 3.53 10.37M 0 -22.01M -18.31M -6.60
VRTX 449.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.04 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 595.85 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.02 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.14 24.89B 3.30B -501.07M 1.03B 11.54

Vaccinex Inc Stock (VCNX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-09-23 다운그레이드 BTIG Research Buy → Neutral
2018-09-04 개시 Ladenburg Thalmann Buy

Vaccinex Inc 주식(VCNX)의 최신 뉴스

pulisher
Nov 18, 2024

Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 18, 2024
pulisher
Nov 18, 2024

Vaccinex Reports Promising Alzheimer's Drug Data, Raises $8.35M Amid Financial Challenges | VCNX Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 15, 2024

Vaccinex Inc (VCNX) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 15, 2024

Vaccinex secures $2.15 million in private placement By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires Shares in Vaccinex Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 08, 2024

Latest Company News - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Vaccinex inks multiple antibody discovery deals using ActivMAb By Investing.com - Investing.com Canada

Nov 08, 2024
pulisher
Nov 07, 2024

Vaccinex inks multiple antibody discovery deals using ActivMAb - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Vaccinex Lands Major Pharma Deals: Amgen, Merck Partner on Breakthrough Antibody Tech | VCNX Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

Vaccinex Reports Improved Immunity Correlating with - GlobeNewswire

Nov 06, 2024
pulisher
Nov 05, 2024

VCNXVaccinex, Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Vaccinex's Pepinemab Breakthrough: New Data Shows Enhanced Cancer Immunotherapy Success | VCNX Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 01, 2024

Vaccinex reports progress in Alzheimer's treatment study By Investing.com - Investing.com Canada

Nov 01, 2024
pulisher
Nov 01, 2024

Vaccinex reports progress in Alzheimer's treatment study - Investing.com India

Nov 01, 2024
pulisher
Oct 31, 2024

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain - Nasdaq

Oct 31, 2024
pulisher
Oct 28, 2024

Vaccinex stock tanks 40% despite positive Alzheimer’s study update - MSN

Oct 28, 2024
pulisher
Oct 25, 2024

Vaccinex Stock Spikes On 'Promising' Data On Alzheimer’s Drug Study: Retail Sentiment Brightens - Barchart

Oct 25, 2024
pulisher
Oct 24, 2024

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024 - GlobeNewswire

Oct 24, 2024
pulisher
Oct 20, 2024

Micron Technology (MU-Q) QuotePress Release - The Globe and Mail

Oct 20, 2024
pulisher
Oct 15, 2024

Orange Juice (OJX25) Quote - The Globe and Mail

Oct 15, 2024
pulisher
Oct 14, 2024

Antibody Library Technology Market Report to 2032 -AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024
pulisher
Oct 09, 2024

Vaccinex faces potential Nasdaq delisting over equity shortfall - Investing.com India

Oct 09, 2024
pulisher
Oct 09, 2024

BTIG Research’s latest rating for VCNX stock - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Vaccinex faces potential Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada

Oct 09, 2024
pulisher
Oct 09, 2024

Company’s Banking Shares: Up -90.42% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle

Oct 09, 2024
pulisher
Oct 09, 2024

Post-Trade Analysis: Vaccinex Inc (VCNX) Slides -27.92, Closing at 1.73 - The Dwinnex

Oct 09, 2024
pulisher
Oct 02, 2024

Vaccinex stock hits 52-week low at $2.98 amid market challenges - Investing.com

Oct 02, 2024
pulisher
Sep 25, 2024

Vaccinex stock hits 52-week low at $4.17 amid sharp annual decline - Investing.com Canada

Sep 25, 2024
pulisher
Sep 25, 2024

VSME’s price-to-free cash flow ratio: What it means for investors - US Post News

Sep 25, 2024
pulisher
Sep 25, 2024

Short Interest in Victory Square Technologies Inc. (OTCMKTS:VSQTF) Declines By 79.4% - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Purchased by Victory Capital Management Inc. - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

WUXI BIO Buys back ~3.32M Shrs for ~$42.55M Ytd - AASTOCKS.com

Sep 24, 2024
pulisher
Sep 24, 2024

Vaxcyte Inc (PCVX) receives a Buy rating from Mizuho - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Victrex plc (LON:VCT) Insider Jane Toogood Acquires 508 Shares - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Victrex Director Buys Shares, Signals Confidence - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

Bank of New York Mellon Corp Boosts Stock Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

StockNews.com Initiates Coverage on Vector Group (NYSE:VGR) - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

VICR Investors Have Opportunity to Lead Vicor Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Sep 23, 2024
pulisher
Sep 23, 2024

The Gross Law Firm Reminds Vicor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2024VICR - PR Newswire

Sep 23, 2024
pulisher
Sep 23, 2024

Victory Capital Management Inc. Has $496,000 Stock Holdings in Zymeworks Inc. (NYSE:ZYME) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Rhumbline Advisers Has $1.01 Million Position in V2X, Inc. (NYSE:VVX) - Defense World

Sep 23, 2024
pulisher
Sep 21, 2024

Choreo LLC Takes Position in Vector Group Ltd. (NYSE:VGR) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

VICOR 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Vicor CorporationVICR - Business Wire

Sep 20, 2024
pulisher
Sep 20, 2024

VICR FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire

Sep 20, 2024
pulisher
Sep 20, 2024

First Eagle Investment Management LLC Purchases 2,067 Shares of V2X, Inc. (NYSE:VVX) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Vaccinex issues new warrants, secures $6.2 million in funding - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Victory Capital Management Inc. Cuts Stake in Wyndham Hotels & Resorts, Inc. (NYSE:WH) - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Vaccinex secures $6.2 million through warrant exercises By Investing.com - Investing.com Canada

Sep 19, 2024
pulisher
Sep 18, 2024

What's Going On With Vaccinex Stock Wednesday? - Benzinga

Sep 18, 2024

Vaccinex Inc (VCNX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):